Stock SHWZ MEDICINE MAN TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medicine Man Technologies, Inc.

Equities

SHWZ

US58468U1060

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 20:59:53 14/05/2024 BST 		5-day change 1st Jan Change
0.45 USD -17.94% Intraday chart for Medicine Man Technologies, Inc. -25.00% -26.19%
04-04 Medicine Man Technologies, Inc. Provides Earnings Guidance for the Year 2024 CI
04-04 Medicine Man Technologies, Inc. Reports Goodwill Impairment for the Fourth Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 107.1 62.48 79.72 77.5 43.68 35.43 -
Enterprise Value (EV) 1 107.1 62.48 79.72 77.5 43.68 35.43 35.43
P/E ratio -5.36 x - - - - - -
Yield - - - - - - -
Capitalization / Revenue - 2.6 x 0.74 x 0.49 x 0.25 x 0.2 x 0.18 x
EV / Revenue - 2.6 x 0.74 x 0.49 x 0.25 x 0.2 x 0.18 x
EV / EBITDA - - 2.48 x 1.49 x 0.82 x 0.76 x 0.61 x
EV / FCF - - - -1.14 x 10.1 x 7.09 x 2.95 x
FCF Yield - - - -87.5% 9.93% 14.1% 33.9%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 39,953 41,933 44,938 54,742 71,634 78,740 -
Reference price 2 2.680 1.490 1.774 1.416 0.6097 0.4500 0.4500
Announcement Date 30/03/20 30/03/21 31/03/22 29/03/23 27/03/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 - 24 108.4 159.4 172.4 174.3 192.5
EBITDA 1 - - 32.17 52.01 53.41 46.33 58
EBIT 1 - -22.9 10.41 20.87 3.289 11.5 24.5
Operating Margin - -95.43% 9.6% 13.09% 1.91% 6.6% 12.73%
Earnings before Tax (EBT) - - - - - - -
Net income -16.98 - - - - - -
Net margin - - - - - - -
EPS -0.5000 - - - - - -
Free Cash Flow 1 - - - -67.79 4.335 5 12
FCF margin - - - -42.53% 2.51% 2.87% 6.23%
FCF Conversion (EBITDA) - - - - 8.12% 10.79% 20.69%
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 30/03/20 30/03/21 31/03/22 29/03/23 27/03/24 - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 31.84 26.52 31.78 44.26 43.19 40.15 40 42.38 46.75 43.32 39.83 41.33 46.83 46.67
EBITDA 1 - 7.502 7.864 15.02 15.86 13.28 14.52 13.81 14.12 10.95 9.5 9 13 13.5
EBIT 1 3.837 3.616 -4.791 9.036 11.11 5.506 5.65 4.957 8.924 -16.26 0.501 2.251 4.251 4.501
Operating Margin 12.05% 13.64% -15.08% 20.41% 25.73% 13.72% 14.12% 11.7% 19.09% -37.52% 1.26% 5.45% 9.08% 9.64%
Earnings before Tax (EBT) - - - - - - - - - - - - - -
Net income - - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - - -
EPS - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 15/11/21 31/03/22 16/05/22 11/08/22 09/11/22 29/03/23 10/05/23 09/08/23 14/11/23 27/03/24 - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - - -67.8 4.34 5 12
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 30/03/20 30/03/21 31/03/22 29/03/23 27/03/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.45 USD
Average target price
2.654 USD
Spread / Average Target
+489.78%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
MEDICINE MAN TECHNOLOGIES, INC. Stock Medicine Man Technologies, Inc.
-26.19% 35.43M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+44.36% 6.34B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-13.52% 4.61B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+10.85% 3.39B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-6.52% 3.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+51.14% 2.02B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-5.22% 1.73B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+1.29% 1.67B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+57.69% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-9.67% 1.59B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. SHWZ Stock
  4. Financials Medicine Man Technologies, Inc.